123 related articles for article (PubMed ID: 1321722)
1. Importance of beta-adrenoceptor function in fat cells for lipid mobilization.
Wahrenberg H; Lönnqvist F; Hellmér J; Arner P
Eur J Clin Invest; 1992 Jun; 22(6):412-9. PubMed ID: 1321722
[TBL] [Abstract][Full Text] [Related]
2. Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells.
Lönnqvist F; Wahrenberg H; Hellström L; Reynisdottir S; Arner P
J Clin Invest; 1992 Dec; 90(6):2175-86. PubMed ID: 1334970
[TBL] [Abstract][Full Text] [Related]
3. Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men.
Hoffstedt J; Arner P; Hellers G; Lönnqvist F
J Lipid Res; 1997 Apr; 38(4):795-804. PubMed ID: 9144094
[TBL] [Abstract][Full Text] [Related]
4. Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives.
Hellström L; Langin D; Reynisdottir S; Dauzats M; Arner P
Diabetologia; 1996 Aug; 39(8):921-8. PubMed ID: 8858214
[TBL] [Abstract][Full Text] [Related]
5. Adipocyte beta-adrenoceptor sensitivity influences plasma lipid levels.
Arner P; Wahrenberg H; Lönnqvist F; Angelin B
Arterioscler Thromb; 1993 Jul; 13(7):967-72. PubMed ID: 8391311
[TBL] [Abstract][Full Text] [Related]
6. Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity--a metabolic predictor of weight loss in obese subjects.
Hellström L; Rössner S; Hagström-Toft E; Reynisdottir S
Int J Obes Relat Metab Disord; 1997 Apr; 21(4):314-20. PubMed ID: 9130030
[TBL] [Abstract][Full Text] [Related]
7. Regulation of lipolysis in fat cells of obese women during long-term hypocaloric diet.
Hellström L; Reynisdottir S; Langin D; Rössner S; Arner P
Int J Obes Relat Metab Disord; 1996 Aug; 20(8):745-52. PubMed ID: 8856398
[TBL] [Abstract][Full Text] [Related]
8. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects.
Van Harmelen V; Lönnqvist F; Thörne A; Wennlund A; Large V; Reynisdottir S; Arner P
Int J Obes Relat Metab Disord; 1997 Nov; 21(11):972-9. PubMed ID: 9368819
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms underlying regional differences in lipolysis in human adipose tissue.
Wahrenberg H; Lönnqvist F; Arner P
J Clin Invest; 1989 Aug; 84(2):458-67. PubMed ID: 2503539
[TBL] [Abstract][Full Text] [Related]
10. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity.
Lönnqvist F; Thöme A; Nilsell K; Hoffstedt J; Arner P
J Clin Invest; 1995 Mar; 95(3):1109-16. PubMed ID: 7883959
[TBL] [Abstract][Full Text] [Related]
11. Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes.
Tavernier G; Barbe P; Galitzky J; Berlan M; Caput D; Lafontan M; Langin D
J Lipid Res; 1996 Jan; 37(1):87-97. PubMed ID: 8820105
[TBL] [Abstract][Full Text] [Related]
12. No difference in the lipolytic response to beta-adrenoceptor stimulation in situ but a delayed increase in adipose tissue blood flow in moderately obese compared with lean men in the postexercise period.
Børsheim E; Lönnroth P; Knardahl S; Jansson PA
Metabolism; 2000 May; 49(5):579-87. PubMed ID: 10831166
[TBL] [Abstract][Full Text] [Related]
13. Regional differences in adrenoceptor binding and fat cell lipolysis in obese, postmenopausal women.
Berman DM; Nicklas BJ; Rogus EM; Dennis KE; Goldberg AP
Metabolism; 1998 Apr; 47(4):467-73. PubMed ID: 9550547
[TBL] [Abstract][Full Text] [Related]
14. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.
Reynisdottir S; Eriksson M; Angelin B; Arner P
J Clin Invest; 1995 May; 95(5):2161-9. PubMed ID: 7738184
[TBL] [Abstract][Full Text] [Related]
15. Adrenergic regulation of lipolysis in fat cells from hyperthyroid and hypothyroid patients.
Wahrenberg H; Wennlund A; Arner P
J Clin Endocrinol Metab; 1994 Apr; 78(4):898-903. PubMed ID: 8157718
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of adipose tissue lipolysis following insulin-induced hypoglycaemia: evidence of increased beta-adrenoceptor-mediated lipolytic response in IDDM.
Bolinder J; Sjöberg S; Arner P
Diabetologia; 1996 Jul; 39(7):845-53. PubMed ID: 8817110
[TBL] [Abstract][Full Text] [Related]
17. Endurance training changes in lipolytic responsiveness of obese adipose tissue.
De Glisezinski I; Crampes F; Harant I; Berlan M; Hejnova J; Langin D; Rivière D; Stich V
Am J Physiol; 1998 Dec; 275(6):E951-6. PubMed ID: 9843736
[TBL] [Abstract][Full Text] [Related]
18. Regulation of beta 3-adrenoceptor expression in white fat cells.
Langin D; Tavernier G; Lafontan M
Fundam Clin Pharmacol; 1995; 9(2):97-106. PubMed ID: 7628838
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells.
Hellmér J; Marcus C; Sonnenfeld T; Arner P
J Clin Endocrinol Metab; 1992 Jul; 75(1):15-20. PubMed ID: 1320047
[TBL] [Abstract][Full Text] [Related]
20. Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans.
Moro C; Crampes F; Sengenes C; De Glisezinski I; Galitzky J; Thalamas C; Lafontan M; Berlan M
FASEB J; 2004 May; 18(7):908-10. PubMed ID: 15033935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
